Search results for " dimethylsulfoxide"
showing 10 items of 33 documents
CCDC 751046: Experimental Crystal Structure Determination
2010
Related Article: J.Vicente, I.Saura-Llamas, J.Turpin, D.Bautista, C.R.de Arellano, P.G.Jones|2009|Organometallics|28|4175|doi:10.1021/om9002895
CCDC 164934: Experimental Crystal Structure Determination
2001
Related Article: H.Grove, J.Sletten, M.Julve, F.Lloret|2001|J.Chem.Soc.,Dalton Trans.||2487|doi:10.1039/b103588f
CCDC 152579: Experimental Crystal Structure Determination
2001
Related Article: M.J.Krische, J.-M.Lehn, N.Kyritsakas, J.Fischer, E.K.Wegelius, K.Rissanen|2000|Tetrahedron|56|6701|doi:10.1016/S0040-4020(00)00489-0
Synthesis, spectroscopic characterization and antiproliferative activity of two platinum(II) complexes containing N-donor heterocycles
2014
Abstract Novel mononuclear complexes of Pt(II), cis -[PtCl 2 (DMSO)HL]·2DMSO ( 1 ), where HL = 7-amino-2-(methylthio)[1,2,4]triazolo[1,5- a ]pyrimidine-6-carboxylic acid and Pt(bdt)Cl 2 ( 2 ), where bdt = [2,4-bis(5,6-diphenyl-1,2,4-triazin-3yl)-pyridine] have been synthesized and characterized by elemental analysis, IR and 1 H NMR spectroscopy and X-ray crystallography diffraction analyses. The molecular structure of ( 1 ) shows that Pt(II) ion has a square planar geometry with N(3) bonded heterocycle ligand, two cis chloride anions and S-bonded dimethylsulfoxide. The antiproliferative activity of complexes ( 1 ) and ( 2 ) has been tested in vitro against HepG2 human hepatoma cells and non…
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
2017
Hyperglycemia associated with inflammation and oxidative stress is a major cause of vascular dysfunction and cardiovascular disease in diabetes. Recent data reports that a selective sodium-glucose co-transporter 2 inhibitor (SGLT2i), empagliflozin (Jardiance®), ameliorates glucotoxicity via excretion of excess glucose in urine (glucosuria) and significantly improves cardiovascular mortality in type 2 diabetes mellitus (T2DM). The overarching hypothesis is that hyperglycemia and glucotoxicity are upstream of all other complications seen in diabetes. The aim of this study was to investigate effects of empagliflozin on glucotoxicity, β-cell function, inflammation, oxidative stress and endothel…
CCDC 885911: Experimental Crystal Structure Determination
2013
Related Article: A.Suhonen, E.Nauha, K.Salorinne, K.Helttunen, M.Nissinen|2012|CrystEngComm|14|7398|doi:10.1039/c2ce25981h
CCDC 778753: Experimental Crystal Structure Determination
2010
Related Article: D.Meshcheryakov, M.Bolte, V.Bohmer|2010|Tetrahedron Lett.|51|1202|doi:10.1016/j.tetlet.2009.12.087
CCDC 204644: Experimental Crystal Structure Determination
2005
Related Article: M.Luostarinen, A.Ahman, M.Nissinen, K.Rissanen|2004|Supramol.Chem.|16|505|doi:10.1080/10610270410001729748
CCDC 633847: Experimental Crystal Structure Determination
2007
Related Article: M.Albrecht, Triyanti, S.Schiffers, O.Osetska, G.Raabe, T.Wieland, L.Russo, K.Rissanen|2007|Eur.J.Org.Chem.|2007|2850|doi:10.1002/ejoc.200700130
CCDC 667519: Experimental Crystal Structure Determination
2008
Related Article: D.Meshcheryakov, F.Arnaud-Neu, V.Bohmer, M.Bolte, V.Hubscher-Bruder, E.Jobin, I.Thondorf, S.Werner|2008|Org.Biomol.Chem.|6|1004|doi:10.1039/b718114k